Despite FDA approval nearly a decade ago, etanercept biosimilar continues to be blocke Sandoz , the global leader in generic and biosimilar medicines, announced the
Amgen announced the presentation of new data across its broad oncology pipeline and portfolio at the European Society for Medical Oncology (ESMO) Congress 2024, taking
Equitable Breakthroughs in Medicine Development (EQBMED) is pleased to announce sponsor companies, Amgen and Merck—known as MSD outside the United States and Canada—have joined the effort to enroll patients in
Fuel up with free Health Tech Insights
